Effectiveness and Safety of Knee Cartilage Lesion Treatment Using CartiONE: 1-to-13 Year Follow-up.

Launched by CARTILAGE REPAIR SYSTEMS BV · Feb 4, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called CartiONE, which is used for repairing knee cartilage lesions. These lesions can cause pain and limit movement in the knee. The trial will look at how effective and safe this treatment has been for patients who received it between 2010 and 2023. Researchers will collect information about these patients' medical histories and their progress after treatment to understand the long-term outcomes.

To participate in the study, patients need to have had the CartiONE treatment for at least six months. They must also have a record of their medical history, including details about any previous knee surgeries. The trial is open to adults aged 65 to 74 from five different countries: Belgium, England, Greece, Poland, and Austria. If someone is considering joining the study, they can expect to share their treatment experiences and may help provide valuable insights into the effectiveness of CartiONE for knee cartilage repair.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients treated with CartiONE for knee cartilage lesion more than 6months prior to inclusion in this study.
• • The study site holds a patient record of all relevant medical history data, including operation reports of any prior knee surgeries, the index-knee surgery report, and posttreatment observations and re-intervention reports, if applicable.
• Exclusion Criteria:
• • Patients cannot be included if any condition exists that is judged by the treating surgeon as making the patient not suited for participation.